RP
RGEN icon

Raelipskie Partnership’s Repligen RGEN Stock Holding History

Raelipskie Partnership’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed -$2.95K – 128
2026
Q1 		$2.95K Hold
25
– – ﹤0.01% 103
2025
Q4 		$4.1K Hold
25
– – ﹤0.01% 97
2025
Q3 		$3.34K Hold
25
– – ﹤0.01% 101
2025
Q2 		$3.11K Hold
25
– – ﹤0.01% 102
2025
Q1 		$3.18K Hold
25
– – ﹤0.01% 102
2024
Q4 		$3.6K Hold
25
– – ﹤0.01% 102
2024
Q3 		$3.72K Hold
25
– – ﹤0.01% 110
2024
Q2 		$3.15K Hold
25
– – ﹤0.01% 88
2024
Q1 		$4.6K Hold
25
– – ﹤0.01% 87
2023
Q4 		$4.5K Buy
+25
New +$3.89K ﹤0.01% 83

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Raelipskie Partnership's RGEN Position: Q2 2026 in Review

Raelipskie Partnership sold out of Repligen (RGEN) in Q2 2026, closing a stake of 25 shares — an estimated $2.95K sold.

Raelipskie Partnership first reported a position in RGEN in Q4 2023 and held it in 10 quarters. The position peaked at $4.6K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Raelipskie Partnership reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Raelipskie Partnership sold 25 Repligen shares in Q2 2026, an estimated $2.95K.
  • Raelipskie Partnership first reported a position in Repligen in Q4 2023 and held it in 10 quarters.
  • Raelipskie Partnership's Repligen position peaked at $4.6K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Raelipskie Partnership's 13F filing for Q2 2026, filed 4 Aug 2026.